TreeFrog Therapeutics
PrivateLast Round
Debt
May 27, 2025
Total Funding Raised
$119.94M
Company Overview
TreeFrog Therapeutics is a biotechnology company that develops a proprietary technology platform for the mass production and differentiation of stem cells to enable safe and affordable cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TreeFrog Therapeutics Comparables
Compare TreeFrog Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PBS Biotech | 77% | |
| Cellevate AB | 76% | |
| Cynata Therapeutics Limited | 73% | |
TreeFrog Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 27, 2025 | ||||
| Corporate Funding | Apr 23, 2024 | ||||
| Series B | Sep 13, 2021 | ||||
| Grant | Sep 5, 2019 | ||||
| Series A | May 13, 2019 | ||||
Grant | Mar 1, 2019 |
Key People
Founding team and executive leadership
TreeFrog Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Leonard Green & Partners | Series B |
| European Innovation Council Fund | Grant |
| European Commission | Grant |
| Ministry of Higher Education and Research | Grant |
| Bpifrance | Grant, Series B |
| European Investment Bank Group | Debt |
| Aquiti Gestion | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Stem cell encapsulator moves from R&D to GMP manufacturing.
- Oct 1, 2025
Collaborating with Vertex Pharmaceuticals on C-STEM technology for diabetes treatment.
TreeFrog Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TreeFrog Therapeutics's valuation, stock price, and market status.